UPDATE: Goldman Sachs Starts Teva Pharma (TEVA) at Neutral
Tweet Send to a Friend
(Updated - July 27, 2020 4:49 AM EDT)
(updating comment)Goldman Sachs analyst Nathan Rich initiates coverage on Teva Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Goldman Sachs analyst Nathan Rich initiates coverage on Teva Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
